NanoDaru Pharmaceutical Company in cooperation with ZIMA Export Management Company, managed to ship the 1st export shipment of its product called “EXOPIO” to Malaysia.
EXOPIO (naltrexone for extended-release injectable suspension) is a monthly treatment to prevent relapse to opioid dependence after opioid detoxification which blocks the opioid receptors and consequently, it would be the best option to treat opioid dependence while being as a part of a comprehensive management program that includes psychosocial methods and social supports.
It is worth pointing out that EXOPIO has no narcotic effects and it is not an addictive medicine.
EXOPIO is regarded as one the most strategic products of NanoDaru’s portfolio which is passing the registration procedure in more than 5 countries and the number of its markets is estimated to be more than 15 markets, by 2024.
#pharmaceutical #export #medicine #psychiatry #neurology #alcoholaddiction #opioidaddiction
